MDCT-Based Radiomics Features for the Differentiation of Serous Borderline Ovarian Tumors and Serous Malignant Ovarian Tumors

References

• Prat J. Pathology of borderline and invasive cancers. Best Pract Res Clin Obstet Gynaecol. 2017;41:15–30. doi:10.1016/j.bpobgyn.2016.08.00728277307
   PubMed Web of Science ®Google Scholar
• Damak T, Ben Hassouna J, Chargui R, et al. Borderline tumors of the ovary. Tunis Med. 2014;92(6):411–416.25741843
   PubMedGoogle Scholar
• Lheureux S, Gourley C, Vergote I, et al. Epithelial ovarian cancer. Lancet. 2019;393(10177):1240–1253. doi:10.1016/S0140-6736(18)32552-230910306
   PubMed Web of Science ®Google Scholar
• Javadi S, Ganeshan DM, Qayyum A, et al. Ovarian cancer, the revised FIGO staging system, and the role of imaging. Am J Roentgenol. 2016;206(6):1351–1360. doi:10.2214/AJR.15.1519927042752
   PubMed Web of Science ®Google Scholar
• Forstner R. Radiological staging of ovarian cancer: imaging findings and contribution of CT and MRI. Eur Radiol. 2007;17(12):3223–3235. doi:10.1007/s00330-007-0736-517701180
   PubMed Web of Science ®Google Scholar
• Zhao SH, Qiang JW, Zhang GF, et al. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol. 2014;24(9):2292–2299. doi:10.1007/s00330-014-3236-424871335
   PubMed Web of Science ®Google Scholar
• Yu X, Liu Y, Jiao J, et al. Evaluation of ovarian tumors with multidetector computed tomography and tumor markers: differentiation of Stage I serous borderline tumors and Stage I serous malignant tumors presenting as solid-cystic mass. Med Sci Monit. 2020;26. doi:10.12659/MSM.924497
   Web of Science ®Google Scholar
• Grabowska-Derlatka L, Derlatka P, Palczewski P, et al. Differentiation of ovarian cancers from borderline ovarian tumors on the basis of evaluation of tumor vascularity in multi–row detector computed tomography—comparison with histopathology. Int J Gynecol Cancer. 2013;23(9):1597–1602. doi:10.1097/IGC.0b013e3182a80a4124172096
   PubMed Web of Science ®Google Scholar
• Denewar FA, Takeuchi M, Urano M, et al. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis. Eur J Radiol. 2017;91:116–123. doi:10.1016/j.ejrad.2017.04.00128629557
   PubMed Web of Science ®Google Scholar
• Nougaret S, Lakhman Y, Molinari N, et al. CT features of ovarian tumors: defining key differences between serous borderline tumors and low-grade serous carcinomas. Am J Roentgenol. 2018;210(4):918–926. doi:10.2214/AJR.17.1825429489407
   PubMed Web of Science ®Google Scholar
• Lambin P, Leijenaar RTH, Deist TM, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14(12):749–762. doi:10.1038/nrclinonc.2017.14128975929
   PubMed Web of Science ®Google Scholar
• He X, Zhang H, Zhang T, et al. Predictive models composed by radiomic features extracted from multi-detector computed tomography images for predicting low- and high- grade clear cell renal cell carcinoma: A STARD-compliant article. Medicine. 2019;98(2):e13957. doi:10.1097/MD.000000000001395730633175
   PubMed Web of Science ®Google Scholar
• Peng J, Zhang J, Zhang Q, et al. A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma. Diagn Interv Radiol. 2018:121–127. doi:10.5152/dir.2018.1746729770763
   PubMed Web of Science ®Google Scholar
• Huang Y, Liu Z, He L, et al. Radiomics signature: a potential biomarker for the prediction of disease-free survival in early-Stage (I or II) non-small cell lung cancer. Radiology. 2016;281(3):947–957. doi:10.1148/radiol.201615223427347764
   PubMed Web of Science ®Google Scholar
• van Griethuysen JJM, Fedorov A, Parmar C, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77(21):e104–e107. doi:10.1158/0008-5472.CAN-17-033929092951
   PubMed Web of Science ®Google Scholar
• Park SY, Oh YT, Jung DC. Differentiation between borderline and benign ovarian tumors: combined analysis of MRI with tumor markers for large cystic masses (≥5 cm). Acta Radiol. 2015;57(5):633–639. doi:10.1177/028418511559726626231948
   PubMed Web of Science ®Google Scholar
• Thomassin-Naggara I, Daraï E, Cuenod CA, et al. Dynamic contrast-enhanced magnetic resonance imaging: A useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging. 2008;28(1):111–120. doi:10.1002/jmri.2137718581400
   PubMed Web of Science ®Google Scholar
• Li YA, Qiang JW, Ma FH, et al. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors. Eur J Radiol. 2018;98:136–142. doi:10.1016/j.ejrad.2017.11.01429279152
   PubMed Web of Science ®Google Scholar
• Thomassin-Naggara I, Aubert E, Rockall A, et al. Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology. 2013;267(2):432–443. doi:10.1148/radiol.1312116123468574
   PubMed Web of Science ®Google Scholar
• Van Calster B, Van Hoorde K, Valentin L, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014;349:g5920. doi:10.1136/bmj.g592025320247
   PubMed Web of Science ®Google Scholar
• Tsili AC, Argyropoulou MI. Adnexal incidentalomas on multidetector CT: how to manage and characterise. J Obstet Gynaecol. 2019:1–8.
   Google Scholar
• Nougaret S, Tardieu M, Vargas HA, et al. Ovarian cancer: an update on imaging in the era of radiomics. Diagn Interv Imaging. 2019;100(10):647–655. doi:10.1016/j.diii.2018.11.00730555018
   PubMed Web of Science ®Google Scholar
• Horvat N, Bates DDB, Petkovska I. Novel imaging techniques of rectal cancer: what do radiomics and radiogenomics have to offer? A literature review. Abdom Radiol. 2019;44(11):3764–3774. doi:10.1007/s00261-019-02042-y
   PubMed Web of Science ®Google Scholar
• Davnall F, Yip CS, Ljungqvist G, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3(6):573–589. doi:10.1007/s13244-012-0196-623093486
   PubMedGoogle Scholar
• Bektas CT, Kocak B, Yardimci AH, et al. Clear cell renal cell carcinoma: machine learning-based quantitative computed tomography texture analysis for prediction of fuhrman nuclear grade. Eur Radiol. 2019;29(3):1153–1163. doi:10.1007/s00330-018-5698-230167812
   PubMed Web of Science ®Google Scholar
• Kurman RJ, Carcangiu ML, Herrington CS, Young RH, eds. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Vol. 6 Geneva, Switzerland: WHO Press; 2014
   Google Scholar
• Berenguer R, Pastor-Juan MDR, Canales-Vázquez J, et al. Radiomics of CT features may be nonreproducible and redundant: influence of CT acquisition parameters. Radiology. 2018;288(2):407–415. doi:10.1148/radiol.201817236129688159
   PubMed Web of Science ®Google Scholar